CoMind

About CoMind

CoMind is revolutionising brain healthcare with its non-invasive technology, redefining how the brain is measured and treated to optimise patient outcomes across the care continuum. Based in London, CoMind designs and manufactures a groundbreaking approach to brain monitoring, which provides a multidimensional view of brain activity using light. It enhances patient safety, improves healthcare economics, and improves clinical outcomes. Their AI-powered platform, CoVision, delivers predictive insights, enabling clinicians to anticipate complications. With a focus on precision medicine, CoMind is setting new standards in brain health, from intensive care to surgeries to the emergency room. CoMind is backed by leading investors such as Octopus Ventures, LocalGlobe, Angelini Ventures and Crane Venture Partners, alongside several high profile angel investors. We are currently hiring for multiple roles.